Prelude Capital Management’s Teladoc Health TDOC Stock Holding History

Prelude Capital Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-6,000	Closed	-$1.15M	–	2333
2020 Q2	$1.15M	Sell	6,000 -2,300	-28%	-$403K	0.06%	280
2020 Q1	$1.29M	Buy	8,300 +5,600	+207%	+$652K	0.09%	167
2019 Q4	$226K	Sell	2,700 -400	-13%	-$30.4K	0.01%	817
2019 Q3	$210K	Buy	+3,100	New	+$204K	0.01%	754
2019 Q1	–	Sell	-1,000	Closed	-$50K	–	2167
2018 Q4	$50K	Buy	1,000 +900	+900%	+$55.1K	﹤0.01%	1111
2018 Q3	$9K	Buy	+100	New	+$7.13K	﹤0.01%	1486

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Prelude Capital Management's TDOC Position: Q2 2026 in Review

Prelude Capital Management reduced its Teladoc Health (TDOC) stake by 77% in Q2 2026, selling an estimated $324K and leaving 14,451 shares worth $123K. The position accounts for 0.01% of the portfolio, ranked #1080.

Prelude Capital Management first reported a position in TDOC in Q1 2020 and has held it in 15 quarters since. The position peaked at $1.31M in Q3 2025. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

Prelude Capital Management held 14,451 shares of Teladoc Health worth $123K as of Q2 2026.
Prelude Capital Management sold 48,634 Teladoc Health shares in Q2 2026, an estimated $324K.
Teladoc Health made up 0.01% of Prelude Capital Management's portfolio in Q2 2026, its #1080 holding.
Prelude Capital Management first reported a position in Teladoc Health in Q1 2020 and has held it in 15 quarters since.
Prelude Capital Management's Teladoc Health position peaked at $1.31M in Q3 2025.
348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.